As of Apr 17
| -0.10 / -2.22%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +59.09% increase from the last price of 4.40.
The current consensus among 3 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.